SUVEN PHARMACEUTICALS
Back to Balance Sheet
|
SUVEN PHARMACEUTICALS Last 5 Year Sundry Debtors History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Sundry Debtors | ₹134 Cr | ₹111 Cr | ₹236 Cr | ₹102 Cr | ₹117 Cr |
What is the latest Sundry Debtors ratio of SUVEN PHARMACEUTICALS ?
Year | Sundry Debtors |
---|---|
Mar2024 | ₹134 Cr |
Mar2023 | ₹111 Cr |
Mar2022 | ₹236 Cr |
Mar2021 | ₹102 Cr |
Mar2020 | ₹117 Cr |
How is Sundry Debtors of SUVEN PHARMACEUTICALS Trending?
Years | Sundry Debtors | % Change | |
---|---|---|---|
Mar2024 | ₹134 Cr | 20.48 | |
Mar2023 | ₹111 Cr | -53.07 | |
Mar2022 | ₹236 Cr | 130.87 | |
Mar2021 | ₹102 Cr | -12.64 | |
Mar2020 | ₹117 Cr | - |
Compare Sundry Debtors of peers of SUVEN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUVEN PHARMACEUTICALS | ₹28,771.1 Cr | 7.1% | 2.5% | 74.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹420,699.0 Cr | 0.6% | -4.6% | 20.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,584.0 Cr | 9.8% | 4.5% | 64.7% | Stock Analytics | |
CIPLA | ₹116,022.0 Cr | -2.9% | -3.9% | 1.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,463.0 Cr | 0.9% | -10.4% | 0.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,434.8 Cr | 0.9% | -0.3% | 27.9% | Stock Analytics |
SUVEN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUVEN PHARMACEUTICALS | 7.1% |
2.5% |
74.1% |
SENSEX | 2% |
0.1% |
8.6% |
You may also like the below Video Courses